From In Silico Hypothesis to Validation: The Role of Real-World Evidence in the Preliminary Verification of AI-Generated Drug-Repositioning Candidates: A Comprehensive Review.

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• AI in Drug Discovery: Clinical Failures, Regulatory Reality, and the Validation Crisis Behind the Hype.#317814
• In Silico Identification of Natural-Product Aromatase (CYP19A1) Inhibitors via Integrated Molecular Docking and QSAR Modelling.#636344
• AI-driven drug reposition for pathogens: a new paradigm in pandemic preparedness.#358264
• THE RESEARCH HORIZON GAP: US Export Controls on Frontier AI as a Structural Biomedical Research Velocity Asymmetry and the Proto-Biological Zero-Day Mechanism#695903
• Designing a Robust LLM-Based Evaluation System for Agentic AI in Drug Discovery Through Human Alignment#662233